1. Health In Tech collaborates with Verdegard to enhance TPA efficiency. 2. Partnership improves quoting and plan design for brokers and employers. 3. Verdegard combines AI technology with pharmacy cost advantages for cost savings. 4. Collaboration targets modernization in the self-funded health insurance market. 5. Enhanced tools offer transparency and agility for small business clients.
This collaboration directly enhances services and operational efficiency, increasing competitive advantage. Historical partnerships in tech-enhanced insurance often lead to revenue growth.
The partnership's focus on technology advancement and cost-saving solutions is highly relevant to HIT's strategic goals which could attract investors.
Immediate operational improvements and service offerings will likely boost client engagement and acquisition quickly. The health insurance landscape often realizes quick benefits from tech integrations.
STUART, Fla., July 24, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is proud to announce a new collaboration with Verdegard Administrators, a licensed third-party administrator (TPA) based in Arizona. Together, the two companies aim to redefine how TPAs support brokers and employer groups by leveraging Health In Tech's Enhanced Do It Yourself Benefit Systems (eDIYBS) platform.
Third-party administrators like Verdegard play a crucial role in the self-funded health insurance market, handling vital services such as:
Verdegard is an integrated, concierge-level TPA owned by MedImpact, the largest independent pharmacy benefit manager (PBM) in the U.S., managing prescription benefits for over 20 million members and processing tens of billions in annual drug transactions. This scale enables Verdegard to offer purchasing power that helps lower drug prices for employer groups—a key advantage for cost-conscious small businesses. By partnering with Health In Tech, Verdegard gains access to advanced digital tools and real-time quoting capabilities that streamline operations, reduce turnaround times, and empower brokers and employers with greater control and transparency.
"Health In Tech is committed to transforming the way TPAs operate," said Dustin Plantholt, Chief Growth Officer at Health In Tech. "Our eDIYBS platform equips partners like Verdegard to be able to quote and implement self-funded health plans faster and more accurately. Combined with Verdegard's pharmacy cost advantages through MedImpact, this collaboration means brokers and employers benefit from agility, cost savings, and a more seamless experience."
Chris Wrba, Vice President of Sales & Marketing at Verdegard Administrators, highlighted the benefits to their clients and broker partners:
"Partnering with Health In Tech allows us to bring next-level efficiency and customization to our services. The eDIYBS platform gives our broker partners the power to generate quotes and plan designs instantly, which enhances our ability to serve employers with tailored solutions and exceptional responsiveness. We're excited about the opportunities this creates for growth and for delivering outstanding value to our clients."
The collaboration between Health In Tech and Verdegard Administrators underscores both companies' dedication to modernizing the self-funded insurance industry and empowering stakeholders across the ecosystem with technology-driven solutions.
Health In Tech (Nasdaq: "HIT") is an Insurtech platform company backed by third-party AI technology, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and TPAs. Learn more at healthintech.com.
Verdegard offers a complete suite of innovative, integrated, and concierge-level services. Plan designs include PPO options, reference-based, level funded, and hybrid plans which provide unique transparency, patient advocacy, and cost containment options to maximize the benefits and savings. Learn more at verdegard.com.
Investor Relations: [email protected]